Keyphrases
COVID-19
100%
Transforming Growth Factor-β
70%
Lung Fibrosis
53%
Fibrocytes
49%
Respiratory Illness
46%
Semaphorin 7A
46%
Viral Infection
46%
Interstitial Lung Disease
46%
Pulmonary Fibrosis
34%
Monocytes
33%
Multisystem Inflammatory Syndrome in children (MIS-C)
31%
Chronic Obstructive Pulmonary Disease
30%
Placebo
29%
Critical Care Medicine
28%
Idiopathic Pulmonary Fibrosis
28%
Alpha-1 Antitrypsin Deficiency
27%
Health Systems
26%
Study Registry
26%
Renin-angiotensin-aldosterone System
26%
Profibrotic
25%
CD45+
25%
Monotherapy
23%
Respiratory Health
23%
Medical Students
23%
System Operation
23%
Hospitalized children
23%
SARS-CoV-2 Infection
23%
N-acetylcysteine
23%
Systemic Sclerosis
23%
Health Status
23%
PICUS
23%
Septic Shock
23%
Age Distribution
23%
Acute Kidney Injury
23%
Regulatory T Cells
23%
Randomized Controlled Trial
23%
High Dose
23%
Rapid Implementation
23%
Esophageal Manometry
23%
Response to COVID-19
23%
Positive End-expiratory Pressure
23%
Chronic Bronchitis
23%
Scleroderma
23%
Circulating Monocytes
23%
Randomized Placebo-controlled Trial
23%
Vitamin C
23%
ICU Staffing
23%
Export Pathways
23%
ANCA-associated Vasculitis
23%
Staffing Models
23%
Medicine and Dentistry
COVID-19
76%
Pulmonary Fibrosis
70%
Fibrinogen
70%
Transforming Growth Factor
70%
Respiratory Disease
49%
Virus Infection
46%
Semaphorin
46%
Severe Acute Respiratory Syndrome Coronavirus 2
41%
Serositis
31%
Disease
30%
Intensive Care Medicine
28%
Alpha 1-Antitrypsin Deficiency
27%
Interstitial Lung Disease
27%
Idiopathic Pulmonary Fibrosis
27%
Continuous Positive Airway Pressure
25%
Monocyte
23%
Programmed Cell Death
23%
SARS Coronavirus
23%
Septic Shock
23%
Regulatory T Cell
23%
Randomized Controlled Trial
23%
Acute Kidney Injury
23%
Infection
23%
Medical Student
23%
Fulminant Hepatic Failure
23%
Monotherapy
23%
Ascorbic Acid
23%
Age Distribution
23%
Alpha 1 Antitrypsin
23%
ANCA Associated Vasculitis
23%
Extubation
23%
Manometry
23%
Renin Angiotensin Aldosterone System
23%
Intensive Care Unit
23%
Patient Care
23%
Health System
23%
Scleroderma
23%
Renin
23%
Angiotensin
23%
Aldosterone
23%
Fibrosis
13%
Lymphocyte
12%
Severe Acute Respiratory Syndrome
11%
Placebo
10%
Silo-Filler's Disease
10%
Respiratory System
10%
Odds Ratio
8%
Trypsin Inhibitor
8%
Critical Illness
7%
Respiratory Failure
7%
